vimarsana.com

Page 4 - தேசிய நிறுவனம் ஆஃப் நோயெதிர்ப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID vaccines: designed for depopulation?

COVID vaccines: designed for depopulation?
canadafreepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from canadafreepress.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJon rappoportBill gatesUte sprengerTask force on vaccines for fertility regulationDevelopment monitorUniversity of guelphCanadian international development research centerUs national institute of child healthProgamme of researchNational institute of immunologyUs agency for international developmentResearch training in human reproductionNational institutes of healthWorld health organization

Single dose sufficient for those who recover from mild Covid, says AIIMS study

However, how long the vaccine will protect, whether it will protect against all circulating and future variants of the virus are questions that need answers for successful implementation of vaccine.

New delhiAshok sharmaAnimesh guptaPoonam coshicDepartment of transfusion medicineBiochemistry departmentEngineering research boardDepartment of scienceNational institute of immunologyNews serviceIntensification of researchIndia institute of medical sciencesExpress newsNational instituteTransfusion medicineAll india institute

Can India re-visit UK s stand on gap between two COVID-19 jabs?

Dr V K Paul, Member (Health), NITI Aayog, has highlighted the need for due scientific process in arriving at such decisions

Tamil naduUnited kingdomNew delhiNarayan kulkarniNaveen khannaGagandeep kangRakesh agarwalGroup onMember healthWorld health organisationChristian medical collegePublic health englandGroup leaderNational institute of immunologyNational technical advisory group on immunisationInternational centre

Single-dose vaccine may be enough for people who have recovered from COVID, says study

The study comes at a time when the country is looking at vaccinating all eligible people (above 18 years) by the year end

New delhiAshok sharmaAnimesh guptaPoonam coshicDepartment of transfusion medicineBiochemistry departmentEngineering research boardDepartment of scienceNational institute of immunologyNews serviceIntensification of researchIndia institute of medical sciencesExpress newsNational instituteTransfusion medicineAll india institute

DBT-NII receives Trademark for India s first indigenous tumour antigen SPAG9

New Delhi [India], June 4 (ANI): India's first indigenous tumour antigen, SPAG9 discovered by Dr Anil Suri, head of Cancer Research Program at Delhi based National Institute of Immunology (NII), an Autonomous Institute of Department of Biotechnology (DBT), in 1998 has received the trademark ASPAGNII, the Ministry of Science and Technology informed on Friday.

Tamil naduNew delhiAtmanirbhar bharatIndia council of medical researchCentre for cancer immunotherapyCancer instituteDepartment of biotechnologyCancer research programDepartment of scienceNational institute of immunologyMinistry of scienceAutonomous institute of department biotechnologyCancer research program at delhiNational instituteAutonomous instituteIndia council

vimarsana © 2020. All Rights Reserved.